FFA
IHE icon

Farther Finance Advisors’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Farther Finance Advisors’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$225K Buy
2,234
+76
+4% +$7.79K ﹤0.01% 2208
2026
Q2 		$214K Buy
2,158
+359
+20% +$32.4K ﹤0.01% 2195
2026
Q1 		$158K Buy
1,799
+487
+37% +$42.6K ﹤0.01% 2191
2025
Q4 		$111K Buy
+1,312
New +$105K ﹤0.01% 2280
2025
Q1 		– Sell
-14
Closed -$923 – 4337
2024
Q4 		$923 Sell
14
-2,468
-99% -$170K ﹤0.01% 3272
2024
Q3 		$175K Buy
2,482
+1,223
+97% +$85.2K 0.01% 1041
2024
Q2 		$83.7K Buy
1,259
+304
+32% +$19.9K ﹤0.01% 1200
2024
Q1 		$64.1K Buy
955
+829
+658% +$54.8K ﹤0.01% 1094
2023
Q4 		$7.79K Buy
+126
New +$7.41K ﹤0.01% 1730

Other funds holding IHE

CCA
Cadent Capital Advisors Tulsa, Oklahoma $466M AUM 30.56% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.01B AUM 28.81% 1-Year Est. Return
PA
Prism Advisors Studio City, California $399M AUM 13.01% 1-Year Est. Return
VWM
Valley Wealth Managers Paramus, New Jersey $1.76B AUM 33.82% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return

Farther Finance Advisors's IHE Position: Q3 2026 in Review

Farther Finance Advisors increased its iShares US Pharmaceuticals ETF (IHE) stake by 3.5% in Q3 2026, buying an estimated $7.79K and bringing the position to 2,234 shares worth $225K. The position accounts for ﹤0.01% of the portfolio, ranked #2208.

Farther Finance Advisors first reported a position in IHE in Q4 2023 and has held it in 9 quarters since. 7 funds tracked by Wall St. Rank hold IHE as of Q3 2026.

  • Farther Finance Advisors held 2,234 shares of iShares US Pharmaceuticals ETF worth $225K as of Q3 2026.
  • Farther Finance Advisors bought 76 iShares US Pharmaceuticals ETF shares in Q3 2026, an estimated $7.79K.
  • iShares US Pharmaceuticals ETF made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #2208 holding.
  • Farther Finance Advisors first reported a position in iShares US Pharmaceuticals ETF in Q4 2023 and has held it in 9 quarters since.
  • 7 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.